Literature DB >> 32985163

[Progress on loss-of-function hypothesis of presenilin-1 mutations in Alzheimer diseases].

Min Yan1, Xu Wang1, Xihan Guo1.   

Abstract

Alzheimer's disease (AD) is an aging-related neurodegenerative disease and is associated with the accumulation of amyloid-β (Aβ) peptides in patient brains. AD can be classified into the familial type and sporadic type. Presenilin-1 (PS1) is the major risk gene for familial AD (fAD) because its mutations comprised over 80%of the total mutations causing fAD. PS1 is the catalytic subunit of the enzyme γ-secretase, which is responsible for the proteolytic cleavage of amyloid precursor protein (APP) to produce Aβ. Although novel fAD-causing mutations in PS1 are being reported increasingly, the molecular mechanisms underlying how these mutations induce fAD remain elusive. Since over 90%of the fAD-causing mutations in PS1 leads to a reduction of γ-secretase activity, the PS1 loss-of-function mutation hypothesis has been emerged, which suggests that the loss of PS1 functions may be the root cause of AD. Recently, increasing number of evidence supports this hypothesis. First, PS1 loss-of-function mutations increase the production of long-length Aβ by disturbing the cleavage sites of γ-secretase APP, thereby increasing the ratio of Aβ42/Aβ40; Second, PS1 loss-of-function mutations dysregulate endoplasmic reticulum calcium homeostasis in neurons; Third, PS1 loss-of-function mutations inhibit the autophagy activity of neurons, resulting in the abnormal accumulation of cleaved products from APP; Fourth, PS1 loss-of-function mutations alter the endocytosis and transcytosis processes in neurons, leading to neuratrophy; Fifth, PS1 loss-of-function mutations activate brain immune cells (astrocytes and microglia), which mount a strong neuroinflammation response; Last, PS1 loss-of-function mutations reduce the rates of glycolysis and the production of lactic acid, disrupting the balance of neuronal energy supply. In this article we summary the research progress on the PS1 loss-of-function hypothesis and pose several topics which would guide studies of this field in future.

Entities:  

Keywords:  Alzheimer disease; Amyloid-β; Loss-of-function mutations; Presenilins; γ-secretase

Mesh:

Substances:

Year:  2020        PMID: 32985163      PMCID: PMC8800746          DOI: 10.3785/j.issn.1008-9292.2020.08.03

Source DB:  PubMed          Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban        ISSN: 1008-9292


  88 in total

Review 1.  Dysregulation of Rab5-mediated endocytic pathways in Alzheimer's disease.

Authors:  Wei Xu; Fang Fang; Jianqing Ding; Chengbiao Wu
Journal:  Traffic       Date:  2018-02-05       Impact factor: 6.215

2.  Presenilin-1 Delta E9 Mutant Induces STIM1-Driven Store-Operated Calcium Channel Hyperactivation in Hippocampal Neurons.

Authors:  Maria Ryazantseva; Anna Goncharova; Kseniia Skobeleva; Maksim Erokhin; Axel Methner; Pavel Georgiev; Elena Kaznacheyeva
Journal:  Mol Neurobiol       Date:  2017-07-13       Impact factor: 5.590

3.  Phosphorylated Presenilin 1 decreases β-amyloid by facilitating autophagosome-lysosome fusion.

Authors:  Victor Bustos; Maria V Pulina; Ashley Bispo; Alison Lam; Marc Flajolet; Fred S Gorelick; Paul Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-22       Impact factor: 11.205

Review 4.  Mosaic loss of human Y chromosome: what, how and why.

Authors:  Xihan Guo; Xueqin Dai; Tao Zhou; Han Wang; Juan Ni; Jinglun Xue; Xu Wang
Journal:  Hum Genet       Date:  2020-02-04       Impact factor: 4.132

5.  Familial Alzheimer disease-linked mutations specifically disrupt Ca2+ leak function of presenilin 1.

Authors:  Omar Nelson; Huiping Tu; Tianhua Lei; Mostafa Bentahir; Bart de Strooper; Ilya Bezprozvanny
Journal:  J Clin Invest       Date:  2007-04-12       Impact factor: 14.808

6.  Presenilin-1 mutations increase levels of ryanodine receptors and calcium release in PC12 cells and cortical neurons.

Authors:  S L Chan; M Mayne; C P Holden; J D Geiger; M P Mattson
Journal:  J Biol Chem       Date:  2000-06-16       Impact factor: 5.157

7.  C99 selectively accumulates in vulnerable neurons in Alzheimer's disease.

Authors:  Maria V Pulina; Maya Hopkins; Vahram Haroutunian; Paul Greengard; Victor Bustos
Journal:  Alzheimers Dement       Date:  2020-01-06       Impact factor: 21.566

8.  Familial Alzheimer's disease presenilin 1 mutation M146V increases gamma secretase cutting of p75NTR in vitro.

Authors:  Caroline Sara Hatchett; Sue Tyler; Dawn Armstrong; David Dawbarn; Shelley Jane Allen
Journal:  Brain Res       Date:  2007-02-07       Impact factor: 3.252

9.  Dysregulation of Nutrient Sensing and CLEARance in Presenilin Deficiency.

Authors:  Kavya Reddy; Corey L Cusack; Israel C Nnah; Khoosheh Khayati; Chaitali Saqcena; Tuong B Huynh; Scott A Noggle; Andrea Ballabio; Radek Dobrowolski
Journal:  Cell Rep       Date:  2016-02-25       Impact factor: 9.423

10.  Aβ43-producing PS1 FAD mutants cause altered substrate interactions and respond to γ-secretase modulation.

Authors:  Johannes Trambauer; Rosa María Rodríguez Sarmiento; Akio Fukumori; Regina Feederle; Karlheinz Baumann; Harald Steiner
Journal:  EMBO Rep       Date:  2019-11-25       Impact factor: 8.807

View more
  1 in total

Review 1.  Role of Calcium Homeostasis in Alzheimer's Disease.

Authors:  Mengqian Ge; Jinghui Zhang; Simiao Chen; Yanfen Huang; Weiyan Chen; Lan He; Yuyan Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2022-03-03       Impact factor: 2.570

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.